By strengthening satiety and appetite regulation, they make it easier to eat less and burn fat
GIP-1 is stimulated by meal intake and glucose-induced hyperosmolarity in the duodenum
GLP1 drugs are FDAapproved medications used to help lower blood sugar in people with Type 2 diabetes
Appetite suppression begins within the first week but remains relatively mild at the 0.25mg starting dose
For example: Semaglutide for diabetes (Ozempic): Start at 0.25 mg weekly for 4 weeks, increase to 0.5 mg, then potentially to 1 mg or 2 mg at 4-week intervals Semaglutide for weight management (Wegovy): Start at 0.25 mg weekly, increasing through 0.5 mg, 1.0 mg, 1.7 mg to 2.4 mg at approximately 4-week intervals Liraglutide for weight management (Saxenda): Start at 0.6 mg daily, increasing by 0.6 mg increments weekly to a target of 3.0 mg daily This titration schedule is evidence-based and should not be accelerated without medical supervision
Mechanism, benefits, and how it works